Archives
-
IAM LC vs LEKC for Pulmonary Drug Permeability
2026-10-02
The reference study directly compares immobilised artificial membrane liquid chromatography (IAM LC) with liposome electrokinetic capillary chromatography (LEKC) for biomimetic drug partitioning and pulmonary permeability assessment. LEKC better captured apparent lung permeability through combined hydrophobic and electrostatic interactions, whereas IAM LC offered broader compound coverage, simpler implementation, and stronger potential for high-throughput screening.
-
Nintedanib: A Genotype-Aware Research Strategy
2026-10-01
Nintedanib (BIBF 1120) is more than a broad-spectrum angiokinase inhibitor: it is a useful probe for connecting receptor tyrosine kinase dependence with ATRX-defined tumor biology. This article translates its kinase profile into genotype-aware assay design, model selection, and translational interpretation.
-
A-1210477 MCL-1 Inhibitor Workflow Guide
2026-10-01
Build more decisive apoptosis experiments with A-1210477, a selective MCL-1 inhibitor for mapping cancer-cell dependence and mitochondrial death signaling. This workflow combines practical handling guidance, orthogonal readouts, combination testing, and troubleshooting for reproducible in vitro cancer research.
-
ALC-0159: An Experimental Design Guide
2026-09-30
ALC-0159 is a PEG-conjugated lipid excipient used to study mRNA lipid nanoparticle performance. This guide connects formulation variables with oncology-relevant assays while separating delivery effects from the broader biology of mRNA vaccination and immune checkpoint inhibition.
-
Sunitinib RTK Workflows for Cancer Models
2026-09-30
Build reproducible Sunitinib assays around RTK signaling, angiogenesis, apoptosis, and genotype-aware drug sensitivity. This workflow connects renal cell carcinoma and nasopharyngeal carcinoma models with the ATRX-deficient glioma findings that can guide combination studies and response stratification.
-
AM 281: CB1 Antagonist Workflow for TBI Research
2026-09-29
AM 281 enables mechanism-focused interrogation of CB1 signaling in traumatic brain injury, glutamate excitotoxicity, and memory impairment research. This workflow connects receptor pharmacology with GLT-1, CREB, neuronal apoptosis, and behavioral endpoints while emphasizing formulation control and assay-specific troubleshooting.
-
MG-132 (Z-LLL-al) Experimental Workflow Guide
2026-09-29
MG-132 (Z-LLL-al) gives researchers a controllable way to connect proteasome blockade with apoptosis, cell-cycle changes, and oxidative stress. This workflow emphasizes dose timing, orthogonal readouts, and careful interpretation when translating proteostasis findings into cancer or antiviral research.
-
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-28
The April 2024 Phytomedicine study identifies sinapine as a chemical probe that targets the PLCβ3 EF-hand region, including Asn-260, to disrupt Gαq–PLCβ3 association and reduce aldosteronism and hypertension in animal models. Its main significance is a more pathway-focused alternative to broad Gαq or pan-PLC inhibition, although the evidence remains preclinical and requires wider validation.
-
Verapamil in Urothelial Hypoxia Research
2026-09-28
A duration-resolved urothelial hypoxia model separates an early hypoxic response from later caspase-1-associated inflammation. Learn how to use Verapamil as a cautious pathway probe, structure matched controls, and troubleshoot interpretation without treating it as a selective TXNIP reagent.
-
PROTACs Target Botulinum Neurotoxin Light Chains
2026-09-27
Tsai and colleagues report proof of principle for using PROTAC-based strategies to direct botulinum neurotoxin catalytic light chains toward proteasomal degradation. The work points to a way to tune toxin persistence, while highlighting that therapeutic clearance and clinical benefit remain questions for further study.
-
MMAE and Tumor Plasticity: A Translational Framework
2026-09-26
Monomethyl auristatin E (MMAE) offers a potent antimitotic payload for antibody-drug conjugate research, while findings on EBV-driven plasticity in nasopharyngeal carcinoma point to a distinct differentiation-based strategy. This article connects the biology without overstating the evidence—and offers practical guidance for testing each approach.
-
Acetoacetic Acid Sodium Salt in Translational Research
2026-09-25
A translational framework for using acetoacetic acid sodium salt to investigate ketone-body biology, diabetes-related metabolic imbalance, and the limits of moving from controlled experiments to clinical interpretation.
-
Smoothened and Olfactory Function in Honeybees
2026-09-25
Guo et al. characterize Smoothened (Smo) in Apis mellifera and use pharmacological modulation to connect Smo expression with olfactory receptor transcripts, antennal responses, and odor-choice behavior. The results support a role for Smo in honeybee olfaction, while leaving open whether the observed effects are direct and how broadly they transfer across species.
-
MG-132 and the Redox Logic of Cancer Cell Death
2026-09-24
MG-132 offers a way to perturb proteasome function and study apoptosis, cell-cycle control, and oxidative stress. This article connects that experimental toolkit to emerging evidence on ACSL1-mediated ferroptosis resistance in ovarian cancer—while distinguishing established findings from the questions researchers still need to test.
-
KG-501 in Macrophage Transcription Assays
2026-09-24
KG-501 offers a practical way to test whether CREB–coactivator signaling contributes to transcriptional changes in macrophages and cancer-cell models. Here, a colitis-associated colorectal cancer study provides a disease-relevant example, while a stepwise workflow explains how to use the compound without mistaking it for a direct TLR4 inhibitor.